Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Molecular basis of physiological heart growth: fundamental concepts and new players.

Maillet M, van Berlo JH, Molkentin JD.

Nat Rev Mol Cell Biol. 2013 Jan;14(1):38-48. doi: 10.1038/nrm3495. Review.

2.

A low fT3 level as a prognostic marker in patients with acute myocardial infarctions.

Zhang B, Peng W, Wang C, Li W, Xu Y.

Intern Med. 2012;51(21):3009-15. Epub 2012 Nov 1.

3.

Thyroid hormone and cardiac repair/regeneration: from Prometheus myth to reality?

Pantos C, Mourouzis I, Cokkinos DV.

Can J Physiol Pharmacol. 2012 Aug;90(8):977-87. doi: 10.1139/y2012-031. Epub 2012 Jul 4. Review.

PMID:
22762197
4.

Thyroid hormone induces sprouting angiogenesis in adult heart of hypothyroid mice through the PDGF-Akt pathway.

Chen J, Ortmeier SB, Savinova OV, Nareddy VB, Beyer AJ, Wang D, Gerdes AM.

J Cell Mol Med. 2012 Nov;16(11):2726-35. doi: 10.1111/j.1582-4934.2012.01593.x.

5.

Thyroid hormone receptor-α and vascular function.

Makino A, Wang H, Scott BT, Yuan JX, Dillmann WH.

Am J Physiol Cell Physiol. 2012 May 1;302(9):C1346-52. doi: 10.1152/ajpcell.00292.2011. Epub 2012 Feb 8.

6.

Control of mitochondrial activity by miRNAs.

Li P, Jiao J, Gao G, Prabhakar BS.

J Cell Biochem. 2012 Apr;113(4):1104-10. doi: 10.1002/jcb.24004. Review.

7.

Thyroid hormone promotes remodeling of coronary resistance vessels.

Savinova OV, Liu Y, Aasen GA, Mao K, Weltman NY, Nedich BL, Liang Q, Gerdes AM.

PLoS One. 2011;6(9):e25054. doi: 10.1371/journal.pone.0025054. Epub 2011 Sep 22.

8.

Transcriptional regulation by nonclassical action of thyroid hormone.

Moeller LC, Broecker-Preuss M.

Thyroid Res. 2011 Aug 3;4 Suppl 1:S6. doi: 10.1186/1756-6614-4-S1-S6.

9.

Role of microRNAs in cardiac remodeling and heart failure.

Topkara VK, Mann DL.

Cardiovasc Drugs Ther. 2011 Apr;25(2):171-82. doi: 10.1007/s10557-011-6289-5. Review.

PMID:
21431305
10.

miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1.

Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP, Li YR, Li PF.

Nat Med. 2011 Jan;17(1):71-8. doi: 10.1038/nm.2282. Epub 2010 Dec 26.

PMID:
21186368
11.

New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

Pantos C, Mourouzis I, Cokkinos DV.

Heart Fail Rev. 2011 Jan;16(1):79-96. doi: 10.1007/s10741-010-9185-3. Review.

PMID:
20668933
12.

Thyroid replacement therapy and heart failure.

Gerdes AM, Iervasi G.

Circulation. 2010 Jul 27;122(4):385-93. doi: 10.1161/CIRCULATIONAHA.109.917922. Review. No abstract available.

13.

The cardiac mitochondrion: nexus of stress.

Baines CP.

Annu Rev Physiol. 2010;72:61-80. doi: 10.1146/annurev-physiol-021909-135929. Review.

PMID:
20148667
14.

Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats.

Forini F, Lionetti V, Ardehali H, Pucci A, Cecchetti F, Ghanefar M, Nicolini G, Ichikawa Y, Nannipieri M, Recchia FA, Iervasi G.

J Cell Mol Med. 2011 Mar;15(3):514-24. doi: 10.1111/j.1582-4934.2010.01014.x.

15.

Thyroid hormone-induced angiogenesis.

Davis PJ, Davis FB, Mousa SA.

Curr Cardiol Rev. 2009 Jan;5(1):12-6. doi: 10.2174/157340309787048158.

16.

miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway.

Li J, Donath S, Li Y, Qin D, Prabhakar BS, Li P.

PLoS Genet. 2010 Jan;6(1):e1000795. doi: 10.1371/journal.pgen.1000795. Epub 2010 Jan 8.

17.

Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload.

Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R.

J Clin Invest. 2010 Jan;120(1):254-65. doi: 10.1172/JCI40295. Epub 2009 Dec 21.

18.

Thyroid hormone in cardiac surgery.

Ranasinghe AM, Bonser RS.

Vascul Pharmacol. 2010 Mar-Apr;52(3-4):131-7. doi: 10.1016/j.vph.2009.11.004. Epub 2009 Nov 27. Review.

PMID:
19945545
19.

A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.

van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN.

Dev Cell. 2009 Nov;17(5):662-73. doi: 10.1016/j.devcel.2009.10.013.

20.

Thyroid hormone and angiogenesis.

Luidens MK, Mousa SA, Davis FB, Lin HY, Davis PJ.

Vascul Pharmacol. 2010 Mar-Apr;52(3-4):142-5. doi: 10.1016/j.vph.2009.10.007. Epub 2009 Oct 30. Review.

PMID:
19879961

Supplemental Content

Support Center